What are the pros and cons of ibuprofen, naproxen, duloxetine (Cymbalta), diclofenac, sulfasalazine, and meloxicam for an adult without specific contraindications?

Medication Comparison for Pain Management

For general pain management in adults without specific contraindications, ibuprofen is the preferred first-line NSAID due to its established efficacy, favorable safety profile, and cost-effectiveness, with naproxen as a close alternative. 1 However, the optimal choice depends critically on the specific pain condition and individual patient risk factors.

NSAIDs: Ibuprofen vs Naproxen vs Diclofenac vs Meloxicam

Ibuprofen (Preferred First-Line)

Pros:

• Lowest cardiovascular risk among commonly used NSAIDs 2, 3
• Recommended as first-line NSAID in cancer pain guidelines 1
• Excellent efficacy for acute pain conditions 4
• Lower cost and widely available
• Does not significantly interfere with aspirin's cardioprotective effects 5
• Dosing: 400-800 mg three times daily (max 3200 mg/day) 1, 6

Cons:

• Higher GI bleeding risk than selective COX-2 inhibitors 2
• Requires multiple daily doses
• Moderate risk for renal toxicity in high-risk patients 1

Naproxen (Strong Alternative)

Pros:

• Best cardiovascular safety profile among all NSAIDs 2, 3
• Twice-daily dosing improves adherence 6
• Does not interfere with aspirin's cardioprotective effects 5
• Effective for chronic pain conditions 4, 7
• Dosing: 250-500 mg twice daily 6

Cons:

• Higher GI bleeding risk than ibuprofen and diclofenac 3, 4
• Slower onset of action compared to ibuprofen
• Not recommended as first-line in guidelines 1

Diclofenac (Use with Caution)

Pros:

• Most potent analgesic effect among NSAIDs 8, 4
• Available in topical formulations (gel, patch) for localized pain 1
• Once-daily extended-release formulation available 6
• Lower GI bleeding risk than naproxen and ibuprofen 8, 4
• Phase 2 metabolism reduces drug-drug interactions 9

Cons:

• Highest cardiovascular risk among traditional NSAIDs 2, 3
• Significantly increased risk of stroke and MI (RR 1.40-1.63) 2, 3
• Increased risk of atrial fibrillation 3
• Should be avoided in patients with cardiovascular disease or risk factors 2
• Higher cost for branded formulations 6

Meloxicam (Selective COX-2)

Pros:

• Once-daily dosing 6
• Lower GI side effects than non-selective NSAIDs 1
• Does not inhibit platelet aggregation 1
• Does not interfere with aspirin 5

Cons:

• No reduction in renal toxicity despite COX-2 selectivity 1
• Cardiovascular risk similar to other NSAIDs 2
• Higher cost than ibuprofen or naproxen 6
• Less robust efficacy data compared to traditional NSAIDs 8

Duloxetine (Cymbalta) - Different Mechanism

Duloxetine is NOT comparable to NSAIDs—it's a first-line agent specifically for neuropathic pain and chronic musculoskeletal pain conditions like fibromyalgia and diabetic neuropathy. 10, 1

Pros:

• First-line for neuropathic pain (diabetic neuropathy, fibromyalgia) 10, 1
• Effective for chronic musculoskeletal pain including osteoarthritis 11, 12
• Can be added to NSAIDs for additional pain relief 12
• Simple dosing: 30 mg daily for 1 week, then 60 mg daily 10, 1
• No GI bleeding, renal, or cardiovascular risks associated with NSAIDs 13
• Beneficial for comorbid depression or anxiety 10, 11

Cons:

• Most common side effect: nausea (reduced by starting at 30 mg) 10, 13, 11
• Contraindicated with MAOIs 13
• Increases bleeding risk when combined with NSAIDs or anticoagulants 13
• Not effective for acute inflammatory pain
• Requires 2-4 weeks for full analgesic effect 10
• Higher cost than NSAIDs 6
• Discontinuation syndrome requires gradual taper 13

Sulfasalazine - Specialized Use Only

Sulfasalazine is NOT an analgesic—it's a disease-modifying antirheumatic drug (DMARD) used exclusively for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis). 14

This medication is not appropriate for general pain management and should only be prescribed by rheumatologists for specific inflammatory conditions.

Contraindications: Intestinal/urinary obstruction, porphyria, sulfonamide hypersensitivity 14

Clinical Decision Algorithm

For Acute Pain (injury, postoperative, dental):

1. Start with ibuprofen 400-600 mg every 6-8 hours 1, 7
2. If inadequate relief, increase to 800 mg three times daily
3. If still inadequate, consider adding acetaminophen or switching to naproxen

For Chronic Inflammatory Pain (osteoarthritis, back pain):

1. Start with topical diclofenac if localized joint pain (knee, hand) 15, 1
2. If topical inadequate or multiple joints: oral ibuprofen or naproxen 15, 7
3. Consider meloxicam if GI intolerance to non-selective NSAIDs 15

For Neuropathic Pain (diabetic neuropathy, fibromyalgia):

1. Start with duloxetine 30 mg daily × 1 week, then 60 mg daily 10, 1
2. Can add gabapentin or pregabalin if partial response 10, 1
3. NSAIDs are generally ineffective for neuropathic pain

For Patients with Cardiovascular Disease:

1. Naproxen is preferred if NSAID needed 2, 3
2. Avoid diclofenac entirely 2, 3
3. Consider duloxetine for chronic pain to avoid NSAID risks 11, 12

For Patients with GI Risk (age >60, history of ulcers, alcohol use):

1. Topical diclofenac for localized pain 15, 1
2. Meloxicam or celecoxib with proton pump inhibitor 1, 15
3. Avoid naproxen (highest GI bleeding risk) 3, 4
4. Consider duloxetine for chronic pain 11, 12

For Elderly Patients (>65 years):

1. Lowest effective dose for shortest duration 1
2. Prefer NSAIDs with phase 2 metabolism (diclofenac) if CV risk low 9
3. Monitor renal function every 3 months 1
4. Consider duloxetine for chronic pain to minimize NSAID exposure 9

Critical Monitoring Requirements for NSAIDs

Baseline assessment: Blood pressure, BUN, creatinine, liver function tests, CBC, fecal occult blood 1

Repeat every 3 months during chronic use 1

Discontinue NSAIDs if:

• BUN or creatinine doubles 1
• Hypertension develops or worsens 1
• Liver function tests increase >3× upper limit of normal 1
• GI bleeding or peptic ulcer develops 1

Common Pitfalls to Avoid

1. Do not use diclofenac in patients with any cardiovascular disease or risk factors—the cardiovascular risk is unacceptably high 2, 3

2. Do not prescribe duloxetine for acute inflammatory pain—it requires weeks to work and is ineffective for this indication 10, 11

3. Do not combine duloxetine with NSAIDs without warning patients about increased bleeding risk 13

4. Do not assume all NSAIDs are equivalent—cardiovascular and GI risks vary significantly 2, 3, 8

5. Do not use sulfasalazine for pain management—it is not an analgesic 14

6. Do not prescribe NSAIDs long-term without monitoring—renal, hepatic, and cardiovascular toxicity can develop insidiously 1